Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 00:05:00 - browse：51256

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： NYU radiologists take on the challenge of expensive MRI machines

WSS

Hospitals look to new technology to keep health care workers safe

Anthos stroke drug appears safer than common blood thinner

Hospitals look to new technology to keep health care workers safe

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

explore

Wikipedia

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

He's a Nobel laureate. Critics say he was misleading on Covid

Hepatitis C has a cure — but many Americans still lack access to it

Why palliative psychiatry is worth discussing

Continuity nursing helped my family in our darkest PICU moments

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Medical records are filled with copy

R1 RCM gets $5.8 billion buyout offer from private equity firm

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Does good food count as health care? Study aims to find out

hotspot

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Ed Silverman on new gene therapies, biosimilars, coffee, and more

CRISPR pioneers react to Casgevy, first gene

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Wegovy, Zepbound and weight loss drugs that preserve muscle

Gain of function research would be limited under House proposal

Wikipedia

hotspot

knowledge

entertainment